课题基金 / 基金详情

HOMOCYSTEINEMIA--A RISK FACTOR FOR OSTEOPOROSIS

HOMOCYSTEINEMIA--A RISK FACTOR FOR OSTEOPOROSIS
同型半胱氨酸血症——骨质疏松症的危险因素
批准号:
2131706
负责人:
CHARLES W PRINCE
金额:
$2.14万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-08-01 至 1995-07-31

项目摘要

项目成果

CHARLES W PRINCE的其他基金

相关文献

中文摘要
翻译
骨质疏松症是一种慢性疾病,在 人口日益庞大,很难诊断和治疗。一个 重要的目标是预防骨质疏松症,尽管它是多因素的 病因学阻碍了对其所有原因的阐明。同型半胱氨酸尿症 由胱硫醚β缺乏所致的先天性代谢错误 合酶活性,其特征是同型半胱氨酸水平升高 血液和脊柱和长骨的严重骨质疏松起病早。 在没有遗传病的情况下,发生同型半胱氨酸血症的可能性, 随着年龄和绝经后的增加而增加,可能是由几个 因素:营养缺乏(维生素B6和叶酸)、吸收不良 (由于维生素B12缺乏、过量饮酒或非类固醇 使用抗炎药物),高蛋氨酸饮食(即高蛋氨酸动物 蛋白质饮食)和/或未知因素。因此,我们的假设是 同型半胱氨酸水平升高是另一个危险因素 骨质疏松。 我们将研究同型半胱氨酸升高对骨细胞的影响 生长、细胞外基质合成、骨形成和骨吸收 通过使用体外方法。大鼠骨髓细胞,在 适宜的培养条件,可诱导成骨或产生 活跃的破骨细胞。我们将添加外源性同型半胱氨酸或使 细胞产生高水平的同型半胱氨酸(通过施加营养 缺陷)和测定对上述参数的影响。因此,我们 应能够评估升高的同型半胱氨酸对两者的影响 骨的动态平衡、形成和吸收的成分 级别。 如果获得了支持我们假设的数据,我们将进行 老年高血压患者血浆同型半胱氨酸水平的横断面研究 没有骨质疏松症,并最终进行了一项干预试验 哪些饮食策略被用来降低同型半胱氨酸水平。
英文摘要
Osteoporosis, a chronic disease causing significant morbidity among an increasingly large population, is difficult to diagnose and treat. An important goal is prevention of osteoporosis, though its multi-factorial etiology has prevented elucidation of all its causes. Homocystinuria, an inborn error of metabolism resulting from deficient cystathionine beta- synthase activity, is characterized by elevated homocysteine levels in blood and early onset of severe osteoporosis of the spine and long bones. The probability of homocysteinemia, in the absence of a genetic disease, increases with age and after menopause and may result from several factors: nutrient deficiencies (vitamin B6 and folic acid), malabsorption (due to vitamin B12 deficiency, excess alcohol intake or non-steroidal anti-inflammatory drug use), a high methionine diet (i.e., a high animal protein diet) and/or unknown factors. Thus, it is our hypothesis that elevated levels of homocysteine represent another risk factor for osteoporosis. We shall investigate the effects of elevated homocysteine on bone cell growth, extracellular matrix synthesis, bone formation and bone resorption by using an in vitro approach. Rat bone marrow cells, under the appropriate culture conditions, can be induced to make bone or to produce active osteoclasts. We shall add exogenous homocysteine or cause the cells to produce elevated levels of homocysteine (by imposing nutrient deficiencies) and assay effects on the parameters named above. Thus, we shall be able to assess the effects of elevated homocysteine on the two components of bone homeostasis, formation and resorption, at functional levels. If data supporting our hypothesis are obtained, we shall undertake a cross-sectional study of plasma homocysteine levels in elderly people with and without osteoporosis and, ultimately, for an intervention trial in which dietary strategies are used to lower homocysteine levels.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HOMOCYSTEINE MODIFIES BONE MATRIX AND MINERALIZATION
HOMOCYSTEINE MODIFIES BONE MATRIX AND MINERALIZATION
Homocysteine's role in the causation of presbyopia
HOMOCYSTEINEMIA--A RISK FACTOR FOR OSTEOPOROSIS